• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pharmaron forms strategic partnership with AstraZeneca

Pharmaron forms strategic partnership with AstraZeneca

October 15, 2012
CenterWatch Staff

Pharmaron, an R&D service provider for the pharmaceutical and biotech industries, is partnering with AstraZeneca to support its global innovative medicines units.

Pharmaron will provide AZ with discovery services in chemistry, drug metabolism and pharmacokinetics (DMPK) and efficacy screening. Pharmaron will conduct these services with a team of several hundred scientists in dedicated research laboratories in its newly opened drug discovery service center in Beijing. The co-location of screening and chemistry services at a single partner is expected to help AZ scientists drive their drug discovery programs with greater efficiency.

Manos Perros, head of infection imed for AZ, said, "We are pleased to enter this strategic partnership with Pharmaron which we believe will help us progress projects through our R&D pipeline more efficiently. Pharmaron scientists will be integrated into our project teams and will play an important role in helping us fulfill our commitment to delivering meaningful medicines to patients worldwide."

Creating novel R&D models for pharmaceutical companies and CROs that nurture pharmaceutical innovation has been Pharmaron's focal point for years, as pharma companies have been seeking integrated partnerships with CROs to optimize their drug discovery and development pipelines. Pharmaron has built technology-based drug discovery service platforms with a focus on key therapeutic areas, as an integrated service partner to pharma and biotech companies.

Founded in 2003, Pharmaron provides R&D services including chemistry, biology, DMPK, pharmacology, chemical development and safety assessment. It has more than 2,000 employees and operations in China and the U.S.

Upcoming Events

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • MachineLearning-360x240.png

    Industry Using AI/ML to Improve Data, Quality and Trial Management, Survey Says

  • VirtualTraining-360x240.png

    Virtual Training Evolves into More In-Depth Learning, Improved Communications

  • SurveywBlueBackground-360x240.png

    Mid-Study Updates Delay Trials At Least a Month, CSDD Report Finds

  • Real-TimeData-360x240.png

    Real-Time Data Helped Sponsors Respond to Sites’ Needs During the Pandemic

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing